An assessment of the prescribing preferences of Irish dermatology consultants for the treatment of severe psoriasis in the setting of a cancer diagnosis

Thumbnail Image
Files
Date
2025-10-01
Authors
Bowe, Stephanie
Murphy, Michelle
Bourke, John
Ryan, Caitriona
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Nature
Published Version
10.1007/s11845-025-04113-0
Research Projects
Organizational Units
Journal Issue
Abstract
Aim: We aimed to investigate the systemic and biologic agent choices of dermatologists in Ireland for those patients with psoriasis and a cancer diagnosis. Methods: An electronic questionnaire was circulated to the Irish Association of Dermatology members using the survey platform, Jotform, between December 2023—June 2025. Results: In total there were 27 responses. Methotrexate was selected most commonly for all scenarios > 5 years remission. In all clinical scenarios, fumaric acid esters were the least frequently selected agents. In general, tumour necrosis factor-alpha inhibitors were the next least commonly selected. Apremilast was selected most commonly for a current malignancy of stage 1 breast cancer (26%), lymphoma (22%) and metastatic RCC (30%). Conclusion: In general, systemic and biologic agents are used by Irish dermatologists in the setting of psoriasis and cancer.
Description
Keywords
Systemic and biologic agent choices , Dermatology , Ireland , Psoriasis , Cancer diagnosis
Citation
Bowe, S., Murphy, M., Bourke, J. and Ryan, C. (2025) 'An assessment of the prescribing preferences of Irish dermatology consultants for the treatment of severe psoriasis in the setting of a cancer diagnosis', Irish Journal of Medical Science, pp.1-8. https://doi.org/10.1007/s11845-025-04113-0
Link to publisher’s version
URI
https://hdl.handle.net/10468/18142
Collections
Medicine - Journal Articles
Copyright
© 2025, the Authors, under exclusive licence to Royal Academy of Medicine in Ireland. Published by Springer Nature. This version of the paper has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1007/s11845-025-04113-0